Myrexis, Inc. (MYRX) –
-
Myrexis (MYRX) Names Jon Couchman as CEO
-
Myrexis, Inc. (MYRX) Declares $2.86 Special Dividend; 102.9% Yield
-
Unusual 11 Mid-Day Movers 11/12: (TIE) (STV) (LDK) Higher; (GALE) (CLVS) (STSI) Lower
-
Mrexis (MYRX) Receives Board Approval to Dissolve Company
-
Myrexis (MYRX) halted with news pending
-
Myrexis (MYRX) CEO Brewer Passes Away; COO Gryska to Assume Role on Interim Bassis
-
Myrexis, Inc. (MYRX) Narrows Q1 Loss to 40c/Share
-
Shares of Myrexis (MYRX) resume trading up about 8%
-
Myrexis (MYRX) to resume trading at 12:50p EST
-
Myrexis (MYRX) to Review Strategic Alternatives
-
Myrexis (MYRX) trading halted with news pending
-
Myrexis, Inc. (MYRX) Reports Q2 Loss of $0.29
-
Myrexis (MYRX) Director Buys 70,218 Shares
-
Myrexis Inc. (MYRX) Director Purchases 101,700 Shares Over Last Two Days
-
Myrexis (NYRX) to Cut Headcount By an Additional 20%; Total Now at 55% for Year
-
Myrexis, Inc. (MYRX) Reports Q1 Loss of $0.33/Share
-
Trading Radar for 11/09: General Motors (GM), Cisco (CSCO), Dean Foods (DF), Green Mountain Coffee (GMCR), Macy's (M), SodaStream (SODA) Report
-
After-Hours Movers 09/08: (DNDN) (ULTA) Higher; (ABM) (VRSN) (MYRX) (KSS) (TXN) Lower
-
Myrexis (MYRX) share resume trading down less than 3%
-
Myrexis (MYRX) shares to resume trading at 4:30pm ET
-
Myrexis, Inc. (MYRX) Posts Narrower than Expected Q4 loss
-
Myrexis (NYRX) Appoints Robert Lollini as CEO
-
Myrexis, Inc. (MYRX) halted; appoints CEO
-
Trading Radar for 09/08: Smithfield Foods (SFD), Ulta Salon (ULTA), Globecomm (GCOM), Verint Systems (VRNT) Report
-
Rodman & Renshaw Starts Myrexis (MYRX) at Market Outperform
-
Morning Movers 05/11: (ROVI) (GCOM) (IPSU) (M) Higher; (IL) (DGLY) (HEV) (STEC) Lower
-
Myrexis, Inc. (MYRX) Narrows Q3 Loss
-
Trading Radar for 05/10: Disney (DIS), Wendy's/Arby's (WEN), Molycorp (MCP), CommVault (CVLT) Report
-
Myrexis (MYRX) Presents Five Posters on Cancer Inhibitor MPC-9528
-
Shares of Myrexis (MYRX) resume trading up 3%
-
Shares of Myrexis (MYRX) to resume trading at 12:45pm ET
-
Myrexis (MYRX) to Close Research Services Unit, Cutting 57 Jobs, Sees $3M in Costs
-
Myrexis (MYRX) trading halted with news pending
-
Myrexis (MYRX) Announces Publication of Phase 2b Azixa Data
-
Myrexis (MYRX) Presents Two Posters for MPC-9528; To File IND with U.S. FDA by End of FY11
-
Myrexis (MYRX) Posts Q1 Loss of $0.40, Beats Views
-
Myrexis (MYRX) Files $80M Mixed Shelf
-
Myrexis (MYRX) Presents Data for MPI-0485520 at ACR/ARHP
-
Myrexis (MYRX) Announces Findings of Tumor Reduction from MPC-9528
-
Myrexis, Inc. (MYRX) Posts Stronger Q4 Results
-
Myriad Pharma (NYRX) Announces Name Change to Myrexis, Inc.
-
Myriad Pharma (MYRX) Announces Efforts to Continue to Focus on Oncology Pipeline; Reduces Workforce by 21
-
Myriad Pharma (MYRX) Presents Data from Two Azixa Phase 2a's
-
Myriad Pharmaceuticals, Inc. (MYRX) Posts Q3 Loss of $0.56, Wider than Views
-
Trading Radar for 05/14: J.C. Penney (JCP), Dilliards (DDS), China TransInfo (CTFO), Varian (VARI), SORL Auto Parts (SORL) Report
-
Javelin Pharma (JAV) Terminates Merger Agreement with Myriad Pharma (MYRX)
-
Notable Mergers and Acquisitions of the Day 04/12: CPKI, DCP, HAL/WEL, JAV/HSP, ABII
-
Javelin Pharma (JAV) Plans to Terminate Merger with Myriad Pharma (MYRX); Javelin Gets Binding Commitment from Hospira (HSP) at $2.20/Share
-
Myriad Pharma (MYRX) Reports Q2 Loss of $0.60
-
Myriad Pharma (MYRX) Announces FDA Accepts Javelin's (JAV) NDA Submission for Dyloject(TM)
Back to MYRX Stock Lookup